Oruka Therapeutics, Inc. (ORKA)
ORKA price $79.92 +0.83 +1.05%
- Ticker
- ORKA
- Price
- $79.92
- Change
- +0.83 +1.05%
- Market cap
- $5.29B
- P/E
- -32.02
- Sector
- Healthcare
- Industry
- Biotechnology
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in…